Woodford Investment Management LLP Buys Gilead Sciences Inc, Bioverativ Inc, Biogen Inc, Sells Northwest Biotherapeutics Inc

May 22, 2017

Investment company Woodford Investment Management LLP buys Gilead Sciences Inc, Bioverativ Inc, Biogen Inc, sells Northwest Biotherapeutics Inc during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Woodford Investment Management LLP. As of 2017-03-31, Woodford Investment Management LLP owns 7 stocks with a total value of $2.4 billion. These are the details of the buys and sells.

Added Positions: GILD, PRTA, BIVV, BIIB, TBPH,
Reduced Positions: ABBV,
Sold Out: NWBO,

For the details of Woodford Investment Management LLP's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Woodford+Investment+Management+LLP

These are the top 5 holdings of Woodford Investment Management LLP

AbbVie Inc (ABBV) - 10,917,258 shares, 29.45% of the total portfolio. Shares reduced by 2.81%
Prothena Corp PLC (PRTA) - 11,106,211 shares, 25.64% of the total portfolio. Shares added by 7.72%
Alkermes PLC (ALKS) - 7,470,528 shares, 18.09% of the total portfolio. Shares added by 0.26%
Theravance Biopharma Inc (TBPH) - 10,705,108 shares, 16.31% of the total portfolio. Shares added by 1.88%
Gilead Sciences Inc (GILD) - 1,588,100 shares, 4.47% of the total portfolio. Shares added by 158.52%

Added: Gilead Sciences Inc (GILD)

Woodford Investment Management LLP added to the holdings in Gilead Sciences Inc by 158.52%. The purchase prices were between $65.59 and $76.38, with an estimated average price of $70.32. The stock is now traded at around $64.36. The impact to the portfolio due to this purchase was 2.74%. The holdings were 1,588,100 shares as of 2017-03-31.

Added: Bioverativ Inc (BIVV)

Woodford Investment Management LLP added to the holdings in Bioverativ Inc by 536.76%. The purchase prices were between $41.82 and $54.46, with an estimated average price of $47.97. The stock is now traded at around $54.69. The impact to the portfolio due to this purchase was 1.5%. The holdings were 791,264 shares as of 2017-03-31.

Added: Biogen Inc (BIIB)

Woodford Investment Management LLP added to the holdings in Biogen Inc by 51.61%. The purchase prices were between $251.68 and $297.85, with an estimated average price of $275.15. The stock is now traded at around $250.04. The impact to the portfolio due to this purchase was 1.45%. The holdings were 376,788 shares as of 2017-03-31.

Sold Out: Northwest Biotherapeutics Inc (NWBO)

Woodford Investment Management LLP sold out the holdings in Northwest Biotherapeutics Inc. The sale prices were between $0.23 and $0.48, with an estimated average price of $0.37.

Here is the complete portfolio of Woodford Investment Management LLP. Also check out:

1. Woodford Investment Management LLP's Undervalued Stocks
2. Woodford Investment Management LLP's Top Growth Companies, and
3. Woodford Investment Management LLP's High Yield stocks
4. Stocks that Woodford Investment Management LLP keeps buying

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.